Why Getinge stock moves
Getinge fell clearly, more than OMX Stockholm 30.
Written after the close on ·
Why today
15,984 news analyzed todayGetinge fell clearly, more than OMX Stockholm 30.
The most likely reason is the sell-off among Healthcare stocks, though no clear company news explains the move.
Over the last five trading days, Getinge was roughly unchanged, as was the market.
Earlier news was mostly analyst target raises after the October report, and the stock trades near its one-year high.
Next, the company reports results on Tuesday 26 January 2027.
Today's move of −1.66% was 2.3 times a normal day's 0.7%. OMX Stockholm 30 moved −1.01% on the same day.
Getinge −1.66%OMX Stockholm 30 −1.01%A little weaker than the market
What analysts expect, and how often they have been right
Analysts’ estimates for Getinge.
Getinge earned more than expected in 7 out of 8 reports.
For comparison, about 46% of reports from Nordic companies beat the estimate in the last three years.
The share moved in the same direction as the earnings surprise in 6 out of 8 reports with a measured move, against about 63% of reports from Nordic companies.
Ratings
Price targets
Latest price 277.80 SEK
Earnings against expectations, and the share’s reaction
Expected EPSAbove estimateBelow estimateAs expectedSEK
Next reported quarter: expected earnings per share of 4.75 SEK (January 26). For the current fiscal year, expected earnings per share changed from 12.63 SEK three months ago to 13.26 SEK now. 2026 estimate: 13.26 SEK. 2027 estimate: 14.63 SEK. People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor. June 8: Buy about 963 thousand SEK. May 29: Buy about 4.7 m SEK. April 28: Buy about 30 m SEK. April 27: Buy about 8.6 m SEK. April 24: Buy about 58 m SEK.
Has the share price followed the business?
Price and earnings moved in the same direction: 2 out of 3 years. Across Nordic companies, that happens in about 60% of years. In 2025, the price changed +21% and earnings per share +38%.
Revenue, profit and market cap
RevenueProfitMarket capHatched bars: analysts’ estimates.bn SEK
Assets, liabilities and market cap
AssetsLiabilitiesMarket capbn SEK
Price and earnings moved in the same direction: 2 out of 3 years.Market cap (Now): 75.7 bn SEKRevenue 2025: 35.0 bn SEK
What the key figures say about Getinge
The figures connect what Getinge earns with what investors pay.
The line shows the share price in the same year, on its own scale. Hatched bars: analysts’ estimates.
Profit divided by the number of shares. Each share represents this much of the earnings.
2022–2025: 6.01 SEK–9.15 SEK. Peers: Sectra 3.22 SEK, Ambu 2.42 DKK, GN Store Nord -1.15 DKK. 2026 estimate: 13.26 SEK (12.04 SEK–14.10 SEK). 2027 estimate: 14.63 SEK (12.92 SEK–16.80 SEK).
What the company sold during the year.
2022–2025: 28.3 bn SEK–35.0 bn SEK. Peers: Sectra 3.7 bn SEK, Ambu 6.2 bn DKK, GN Store Nord 14.8 bn DKK. 2026 estimate: 35.4 bn SEK (35.2 bn SEK–35.6 bn SEK). 2027 estimate: 37.7 bn SEK (36.9 bn SEK–38.6 bn SEK).
The percentage of revenue left after the costs of running the business.
2022–2025: 10.6%–13.7%. Peers: Sectra 20.9%, GN Store Nord 3.6%.
Profit as a percentage of shareholders’ money in the company.
2022–2025: 5.0%–8.3%. Peers: Sectra 28.3%, Ambu 8.4%, GN Store Nord 2.6%.
The price investors pay for each unit of annual earnings per share. Not shown for a loss.
2022–2025: 23.6–30.2. Peers: Sectra 101.7, Ambu 36.2. 2026 estimate: 20.9. 2027 estimate: 19.0.
What investors pay for each unit the company sells.
2022–2025: 1.42–2.08. Peers: Sectra 16.86, Ambu 3.66, GN Store Nord 1.22. 2026 estimate: 2.14. 2027 estimate: 2.01.
Money paid to shareholders per share, summed by calendar year.
2017–2025: 1.00 SEK–4.60 SEK.
The ordinary yearly dividend as a percentage of the share price.
2022–2025: 1.8%–2.4%. Peers: Sectra 0.4%, Ambu 0.5%, GN Store Nord 0.0%.
Net debt divided by operating earnings before depreciation and amortisation.
2022–2025: 0.03–1.46. Peers: Sectra -2.00, Ambu -0.14, GN Store Nord 3.56.
More key figures
Market cap divided by shareholders’ equity, what remains after liabilities.
2022–2025: 1.50–2.03. Peers: Sectra 27.19, Ambu 3.76, GN Store Nord 1.71.
Market cap plus net debt, divided by operating earnings. This includes debt.
2022–2025: 16.1–19.8.
Cash left after investments, divided by the number of shares.
2022–2025: 5.89 SEK–12.00 SEK. Peers: Sectra 4.00 SEK, GN Store Nord 0.92 DKK.
The percentage of assets financed by shareholders’ equity.
2022–2025: 51.6%–57.7%.
The dividend explained
A dividend is money paid to shareholders. Getinge paid 4.75 SEK per share in the twelve months through November 6, 2026.
On the ex-dividend day, April 22, 2026, Getinge traded without the right to the 4.75 SEK dividend. The price went from 198.20 SEK to 196.00 SEK; including the dividend, the day's change was +1.3%. Entitlement passes from the company to shareholders on the ex-day; payment comes later.
2017: 1.89 SEK2018: 1.50 SEK2019: 1.00 SEK2020: 1.50 SEK2021: 3.00 SEK2022: 4.00 SEK2023: 4.25 SEK2024: 4.40 SEK2025: 4.60 SEK2026 so far: 4.75 SEK
What to watch next, and why
The earnings report shows how Getinge's revenue and profit have changed.
- Earnings report
The earnings report shows how Getinge's revenue and profit have changed.
Add to calendar
More about Getinge
Insider trades
People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor.
- Johan Bygge, board memberBuyabout 963 thousand SEK
- MATTIAS PERJOS, CEOBuyabout 4.7 m SEK
- Carl Bennet, board member (closely associated)Buyabout 30 m SEK
- Carl Bennet, board member (closely associated)Buyabout 8.6 m SEK
- Carl Bennet, board member (closely associated)Buyabout 58 m SEK
Earnings report
Next report: · Add to calendar · Google Calendar
On its last 15 report days Getinge usually moved about 5.5%. On a normal day it moves 0.7%.
+2.00% Why? +10.14% −1.34% −5.78%
10,000 SEK in Getinge bought on November 7, 2016 is worth 26,800 SEK today, with dividends reinvested.
What would 10,000 SEK in Getinge be worth today? →
What would 10,000 SEK in Getinge be worth today?
26,800 SEK
with dividends reinvested, bought on November 7, 2016.
At worst it was worth 6,370 SEK (October 15, 2018).
The five biggest days of the journey
· −18.4% · the whole market was unchanged the same day
· −17.5% · the whole market rose 0.8% the same day
· −16.2% · the whole market fell 1.3% the same day
· +16.1% · the whole market rose 0.9% the same day · report day
· −15.2% · the whole market fell 1.6% the same day · report day
Earlier days
+0.04% market −0.11% Getinge was roughly flat over the week. Read →
Getinge was roughly flat over the week.
The OMX Stockholm 30 index was also roughly flat.
The shares fell clearly in the last session, more than the market did.
Most of the week's news came before the window.
+1.25% market −0.32% Getinge rose, moving against a slightly weaker OMX Stockholm 30. Read →
Getinge rose, moving against a slightly weaker OMX Stockholm 30.
No company news from that session explains the move.
Over the last five trading days it rose clearly, more than the market, which edged up.
Several analysts raised their price targets after the October results, and Handelsbanken upgraded to buy, which supports the share price.
Next, watch the earnings report on Tuesday 26 January 2027.
+2.46% market +0.83% Getinge rose sharply, clearly more than the market. Read →
Getinge rose sharply, clearly more than the market.
No company news from that session explains the move.
Over the last five trading days it rose clearly, while OMX Stockholm 30 rose slightly.
Earlier news from the week includes a sell-side downgrade on Monday, which is before the session, and a series of raised price targets after the October results.
Analysts' price targets are estimates of fair share price, and that wave of raises likely supports the stock.
−0.37% market −0.08% Getinge slipped slightly without a company-news explanation. Read →
Getinge slipped slightly without a company-news explanation.
Over the last five trading days the stock edged up, in line with a modestly higher OMX Stockholm 30.
The session move was an ordinary one for Getinge, on around its usual trading volume.
The latest news is older: AlphaValue/Baader Europe downgraded Getinge to reduce yesterday, and several brokers raised their target prices after the October results, which analysts see as the fair share price.
The stock sits near its highest close of the past year, well above its lowest in mid March.
−1.58% market +0.48% Getinge fell clearly, against a slightly rising market. Read →
Getinge fell clearly, against a slightly rising market.
No company news explains this move.
Over the last five trading days, Getinge rose clearly, in line with the market.
Its latest close sits near its highest level of the past year.
Analysts raised their price targets after the October report, which supports the stock.
+1.57% market −0.29% Getinge rose, moving against a slightly weaker OMX Stockholm 30. Read →
Getinge rose, moving against a slightly weaker OMX Stockholm 30.
No company news explains the move.
Over the last five trading days, Getinge rose sharply, in line with the market.
Earlier results and analyst target-price raises after the quarterly report are likely behind the strong week.
Trading volume was around its usual level, and the share price is near its highest close of the past year.
+3.74% market +3.01% Getinge rose sharply over the week, moving in line with the broader OMX Stockholm 30 market, which also rose clearly. Read →
Getinge rose sharply over the week, moving in line with the broader OMX Stockholm 30 market, which also rose clearly.
The main driver was a wave of analyst upgrades after the October 21 quarterly report, which beat expectations on better margins and strong cash flow.
Analysts including DNB Carnegie, ABG Sundal Collier, SEB, Nordea and Handelsbanken raised their price targets on October 22, and Handelsbanken also upgraded the shares to buy.
Within the week, Getinge announced on October 26 that Acute Care Therapies president Elin Frostehav is leaving, which was dated news but did not stop the rally.
+0.55% market +0.41% Getinge rose, moving in line with the market. Read →
Getinge rose, moving in line with the market.
Analysts raised their price targets after the strong quarterly report, and Handelsbanken upgraded the stock to buy.
Over the last five trading days the shares rose clearly, in step with OMX Stockholm 30, which also rose sharply.
The move was an ordinary one for Getinge.
Most likely the upgrade and higher targets, partly after last week's earnings beat, supported the shares.
+2.33% market −3.67% Getinge rose clearly over the last five trading days, while the wider Stockholm market fell sharply. Read →
Getinge rose clearly over the last five trading days, while the wider Stockholm market fell sharply.
The move was ordinary in size and came mainly after the company's Q3 report earlier this week, which beat expectations.
Profit margin, the share of sales left as operating profit, rose sharply, helped partly by tariff refunds and currency effects.
Several analysts then raised their price targets, the share price they see as fair, and Handelsbanken upgraded the shares to buy.
+2.00% market +0.17% Getinge rose sharply on its Q3 report, which beat expectations. Read →
Getinge rose sharply on its Q3 report, which beat expectations.
Getinge rose clearly over the last five trading days, while OMX Stockholm 30 fell slightly, so it moved against the market.
Its quarterly report, published in the last session, showed organic sales and order growth, plus a higher profit margin of 15.1%.
Part of that margin gain came from one-off tariff refunds and currency effects, so underlying profitability improved more modestly.
Trading volume was about twice a normal session, and the share closed at its highest level of the past year.
+0.93% market +1.25% Getinge rose clearly, alongside a strong Stockholm market, most likely helped by the Q3 consensus estimates published that day. Read →
Getinge rose clearly, alongside a strong Stockholm market, most likely helped by the Q3 consensus estimates published that day.
Over the last five trading days the stock rose clearly, outpacing the OMX Stockholm 30, which rose slightly.
Watch the report on 21 October, when the actual results can be compared with the consensus estimates (the average of analysts' forecasts).
Learn more · Why do stocks go up and down?